Cargando…

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells

OBJECTIVE: It has been shown that SOCS-1 plays an important role in the proper control of cytokine/growth factor responses and acts as a tumor suppressor in acute myeloid leukemias. Therefore, the objective of the present study was to evaluate the in vitro effect of treatment with Nutlin-3, a small...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tisato, Veronica, Norcio, Alessia, Celeghini, Claudio, Milani, Daniela, Gonelli, Arianna, Secchiero, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870313/ https://www.ncbi.nlm.nih.gov/pubmed/24473562 http://dx.doi.org/10.6061/clinics/2014(01)10

Ejemplares similares

Levels of circulating TNF-related apoptosis-inducing ligand in celiac disease
por: CELEGHINI, CLAUDIO, et al.
Publicado: (2014)

Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors
por: Rimondi, Erika, et al.
Publicado: (2021)

TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications
por: Perri, Paolo, et al.
Publicado: (2015)

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?
por: Vaccarezza, Mauro, et al.
Publicado: (2020)

Clinical perspectives of TRAIL: insights into central nervous system disorders
por: Tisato, Veronica, et al.
Publicado: (2016)

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
por: Tisato, Veronica, et al.
Publicado: (2017)

Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3
por: Agnoletto, Chiara, et al.
Publicado: (2014)

Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members
por: Gonelli, A., et al.
Publicado: (2009)

TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019)

Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
por: Fontana, Maria Chiara, et al.
Publicado: (2021)

A MONOCLONAL ANTIBODY THAT RECOGNIZES A COMMON ANTIGEN IN MYELOID AND HUMAN T‐CELL LEUKEMIA VIRUS TYPE I‐CARRYING CELLS
por: Takeuchi, Tamotsu, et al.
Publicado: (1988)

Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia
por: Jin, Zhenyi, et al.
Publicado: (2016)

Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia
por: Zha, Xianfeng, et al.
Publicado: (2012)

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
por: Fields, Matteo, et al.
Publicado: (2023)

Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia
por: Brinton, Lindsey T., et al.
Publicado: (2020)

Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia
por: Haaland, Ingvild, et al.
Publicado: (2014)

Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation
por: Sun, Yuening, et al.
Publicado: (2022)

Adult T‐cell Leukemia in Spouses
por: Sanada, Isao, et al.
Publicado: (1989)

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort
por: Juskevicius, Darius, et al.
Publicado: (2017)

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation
por: Schläfli, Anna M, et al.
Publicado: (2012)

Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
por: Zauli, Giorgio, et al.
Publicado: (2020)

Mutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2016)

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
por: Hansen, N, et al.
Publicado: (2013)

Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome‐wide cDNA Microarray Analysis
por: Kaneta, Yasuyuki, et al.
Publicado: (2002)

Simultaneous Expression of T‐Cell and Myeloid Cell Phenotypes in Eight Newly Established HTLV‐I‐positive T‐Cell Lines
por: Koizumi, Shigeki, et al.
Publicado: (1992)

PRODUCTION OF PARATHYROID HORMONE‐RELATED PROTEIN IN ADULT T‐CELL LEUKEMIA CELLS
por: Honda, Satoshi, et al.
Publicado: (1988)

Transformation of Animal Cells with Human T‐Cell Leukemia Virus Type II
por: Miyamoto, Kanji, et al.
Publicado: (1990)

Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature
por: Gallo, Stefania, et al.
Publicado: (2018)

Multi‐step Carcinogenesis Model for Adult T‐cell Leukemia
por: Okarmoto, Takashi, et al.
Publicado: (1989)

TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
por: Tisato, Veronica, et al.
Publicado: (2018)

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
por: Wei, Andrew H., et al.
Publicado: (2019)

Identification of Genes Associated with the Progression of Adult T Cell Leukemia (ATL)
por: Kohno, Tomoko, et al.
Publicado: (2000)

Awakening p53 in senescent cells using nutlin-3
por: Schug, Thaddeus T.
Publicado: (2009)

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
por: Lancet, Jeffrey E., et al.
Publicado: (2018)

EXPRESSION OF CR2 (C3d RECEPTOR) ON THE CELL MEMBRANES OF ADULT T CELL LEUKEMIA
por: Kai, Chieko, et al.
Publicado: (1988)

Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy
por: Tisato, Veronica, et al.
Publicado: (2015)

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2020)

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation
por: Zauli, Giorgio, et al.
Publicado: (2022)

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
por: Faraoni, Isabella, et al.
Publicado: (2012)

Aberrant Expression of the p53 Tumor Suppressor Gene in Adult T‐Cell Leukemia and HTLV‐I‐infected Cells
por: Yamato, Kenji, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_14ogbe31f6lb5i0lqalik632l7